23 May 2013
6 April 1992
Swedish drugmaker Fermenta reported a 1.23 billion kroner ($203.4 million) loss for 1991, compared with a loss of 599 million...
6 April 1992
NEW YORK: share prices moved up and down during the reporting week, first with lower car sales pushing the Dow...
6 April 1992
Eliminating the "best price" provision from the US Medicaid rebate formula for the top 100 single-source and innovator multiple-source drugs...
6 April 1992
People in the US Food and Drug Administration-regulated industries now recognize that the time has arrived for user fees to...
6 April 1992
The ICN Hubber Group is investing 1.7 billion pesetas ($2.2 million) in a new pharmaceutical plant near Barcelona in Spain....
6 April 1992
Lionel Brisson of France has been appointed as director of program development and monitoring in the Office of the Director-General...
6 April 1992
The sale of British Technology Group by the UK government to a management and employee buy-out consortium was completed at...
6 April 1992
Hoffmann-La Roche's reversible inhibitor of monoamine oxidase type A, Aurorix (moclobemide) has now been launched in Australia. The novel antidepressant...
6 April 1992
Highlighting the most prominent products and product candidates in its commercial development pipeline, Genetics Institute acknowledges that significant progress has...
6 April 1992
In line with the group's overall international performance, Bayer Italia reports lower sales and profits in 1991. The subsidiary of...